Unknown

Dataset Information

0

Direct control of hepatic glucose production by interleukin-13 in mice.


ABSTRACT: Hyperglycemia is a result of impaired insulin action on glucose production and disposal, and a major target of antidiabetic therapies. The study of insulin-independent regulatory mechanisms of glucose metabolism may identify new strategies to lower blood sugar levels. Here we demonstrate an unexpected metabolic function for IL-13 in the control of hepatic glucose production. IL-13 is a Th2 cytokine known to mediate macrophage alternative activation. Genetic ablation of Il-13 in mice (Il-13-/-) resulted in hyperglycemia, which progressed to hepatic insulin resistance and systemic metabolic dysfunction. In Il-13-/- mice, upregulation of enzymes involved in hepatic gluconeogenesis was a primary event leading to dysregulated glucose metabolism. IL-13 inhibited transcription of gluconeogenic genes by acting directly on hepatocytes through Stat3, a noncanonical downstream effector. Consequently, the ability of IL-13 to suppress glucose production was abolished in liver cells lacking Stat3 or IL-13 receptor ?1 (Il-13r?1), which suggests that the IL-13R?1/Stat3 axis directs IL-13 signaling toward metabolic responses. These findings extend the implication of a Th1/Th2 paradigm in metabolic homeostasis beyond inflammation to direct control of glucose metabolism and suggest that the IL-13/Stat3 pathway may serve as a therapeutic target for glycemic control in insulin resistance and type 2 diabetes.

SUBMITTER: Stanya KJ 

PROVIDER: S-EPMC3533296 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


Hyperglycemia is a result of impaired insulin action on glucose production and disposal, and a major target of antidiabetic therapies. The study of insulin-independent regulatory mechanisms of glucose metabolism may identify new strategies to lower blood sugar levels. Here we demonstrate an unexpected metabolic function for IL-13 in the control of hepatic glucose production. IL-13 is a Th2 cytokine known to mediate macrophage alternative activation. Genetic ablation of Il-13 in mice (Il-13-/-) r  ...[more]

Similar Datasets

| S-EPMC4755301 | biostudies-literature
| S-EPMC2940466 | biostudies-literature
| S-EPMC4130186 | biostudies-literature
| S-EPMC4197140 | biostudies-literature
| S-EPMC8167890 | biostudies-literature
| S-EPMC6951436 | biostudies-literature
| S-EPMC3023473 | biostudies-literature
| S-EPMC3287225 | biostudies-literature
| S-EPMC3131508 | biostudies-literature
2014-08-20 | E-GEOD-60527 | biostudies-arrayexpress